These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32222441)

  • 1. An Anomalous Mechanism Causing Failure of Expanded Polytetrafluoroethylene-Covered Nitinol Stents, Evaluated Using Multiple Intravascular Imaging Modalities.
    Kobayashi N; Takano M; Miyauchi Y; Shimizu W
    JACC Cardiovasc Interv; 2020 Apr; 13(8):e73-e75. PubMed ID: 32222441
    [No Abstract]   [Full Text] [Related]  

  • 2. Angioscopic Findings on 15-Month Follow-Up for Interwoven Nitinol Stent Invagination in the Femoropopliteal Artery.
    Nakama T; Obunai K; Muraishi M; Kojima S; Watanabe H
    JACC Cardiovasc Interv; 2020 Aug; 13(16):1958-1959. PubMed ID: 32739298
    [No Abstract]   [Full Text] [Related]  

  • 3. Endoscopic Findings of an Excessively Compressed Interwoven Nitinol Supera Stent.
    Sugihara M; Miura SI
    Circ J; 2020 Apr; 84(5):830. PubMed ID: 32224578
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular response to paclitaxel-eluting nitinol self-expanding stent in superficial femoral artery lesions: post-implantation angioscopic findings from the SHIMEJI trial (Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral stent in Japanese patients with the Infra inguinal lesion: serial angioscopic observation).
    Tsukiyama Y; Shinke T; Ishihara T; Otake H; Terashita D; Kozuki A; Fukunaga M; Zen K; Horimatsu T; Fujii K; Shite J; Uematsu M; Takahara M; Iida O; Nanto S; Hirata KI
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1777-1784. PubMed ID: 31201589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
    Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
    J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-expanding nitinol stents of high versus low chronic outward force in de novo femoropopliteal occlusive arterial lesions (BIOFLEX-COF trial): study protocol for a randomized controlled trial.
    Wressnegger A; Kaider A; Funovics MA
    Trials; 2017 Dec; 18(1):594. PubMed ID: 29237489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament.
    Calligaro KD; Balraj P; Moudgill N; Rao A; Dougherty MJ; Eisenberg J
    J Vasc Surg; 2013 Feb; 57(2):421-6. PubMed ID: 23058723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Stent Grafts and Helical-Woven Bare-Metal Stents in the Superficial Femoral and Popliteal Arteries.
    Madassery S; Turba UC; Arslan B
    Tech Vasc Interv Radiol; 2016 Jun; 19(2):153-62. PubMed ID: 27423997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
    Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G
    J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crushed stent with acute occlusion in superficial femoral artery after enhanced external counterpulsation.
    Suh Y; Ko YG; Lee SH; Kim MD; Choi D
    JACC Cardiovasc Interv; 2014 Oct; 7(10):e141-2. PubMed ID: 25240552
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
    Armstrong EJ; Jeon-Slaughter H; Kahlon RS; Niazi KA; Shammas NW; Banerjee S
    J Endovasc Ther; 2020 Feb; 27(1):60-65. PubMed ID: 31686573
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of Vascular Patency and Inflammation with Intravascular Optical Coherence Tomography in Patients with Superficial Femoral Artery Disease Treated with Zilver PTX Stents.
    Hoyt T; Feldman MD; Okutucu S; Lendel V; Marmagkiolis K; McIntosh V; Ates I; Kose G; Mego D; Paixao A; Iliescu C; Park J; Shaar M; Avci R; McElroy A; Dijkstra J; Milner TE; Cilingiroglu M
    Cardiovasc Revasc Med; 2020 Jan; 21(1):101-107. PubMed ID: 31395436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Response After FP-PES Versus Polymer-Free Paclitaxel-Eluting Stent Implantation in Femoropopliteal Artery Lesions: A Serial Intravascular Ultrasound Study.
    Tomoi Y; Kuramitsu S; Soga Y; Fujihara M; Iida O; Kawasaki D; Ando K
    JACC Cardiovasc Interv; 2020 Feb; 13(4):535-537. PubMed ID: 32081246
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravascular ultrasound guided directional atherectomy versus directional atherectomy guided by angiography for the treatment of femoropopliteal in-stent restenosis.
    Krishnan P; Tarricone A; K-Raman P; Majeed F; Kapur V; Gujja K; Wiley J; Vasquez M; Lascano RA; Quiles KG; Distin T; Fontenelle R; Atallah-Lajam F; Kini A; Sharma S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):17-22. PubMed ID: 29265002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
    de Grijs D; Teixeira P; Katz S
    J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should we manage thrombosis of Viabahn stent-graft? A case report focused on catheter-directed thrombolysis.
    Kang WY; Campia U; Bernardo NL; Didier RJ; Negi SI; Kiramijyan S; Koifman E; Baker NC; Lipinski MJ; Escarcega RO; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2016 Mar; 17(2):134-7. PubMed ID: 26994746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.